dynamiccontrastenhancedmri-thegynecologiccancerintergroup.pptVIP

座机电话号码 Missed on CT. Seen on PET A generalized tracer kinetic model which is more physiologically meaningful than descriptors such as IAUC initial area under the constrast agent concentration-time curve . Model is independent of acquisition protocol and solely reflects the tissue characteristics. Breast cancer accrual completed in 2006, glioblastoma trial accrual completed 2009 SER signal enhancement ratio, ratio of enhancement at 2.5 min vs. 7.5 min, i.e. measures early washout . Imaging after 1 cycle of doxorubicin-cyclophosphamide AC , the after completion AC and taxane prior to surgery USPIO is chemical class name, ferumoxatran 10 generic name, Combidex USA and Sineram Europe Liver often in conjunction with chemo or radio catheter embolization 座机电话号码 Adhesions from previous divertiulitis surgery. 座机电话号码 RF ablation. 座机电话号码 RF ablation. Second site of RF in right pelvis a year later. PET-CT negative for disease 3 years post ablation 座机电话号码 High grade Muellerian ca. S/p posterior exenteration, carbo/taxol, consolidative pelvic radiation. 座机电话号码 High grade Muellerian ca. S/p posterior exenteration, carbo/taxol, consolidative pelvic radiation. No RF site recurrence. Pelvic mass treated with chemo. Boston harbor at sunrise. Imaging Questions in Ovarian Cancer Susanna I. Lee, MD, PhD Emerging Technologies PET-CT Perfusion imaging Dynamic contrast enhanced CT DCE-CT Dynamic contrast enhanced MRI DCE MRI Nodal imaging Ultrasmall superparamagnetic iron oxide USPIO MRI Diffusion weighted imaging DWI MRI Percutaneous tumor ablation 22,975 studies from 1,178 centers over 1 year 15% patients with gynecologic cancers 2,096 ovarian 1,198 uterine corpus 434 cervix Query referring physician on intended patient management before and after PET-CT PET Impact on Management Hillner BE et al. J Clin Oncol 2008. 26:2155 PET-CT in Recurrence no treatment treatment PET-CT in Recurrence surgery chemotherapy PET-CT in Recurrence CT alone PET-CT Sensitivity 9